Effect of cabergoline treatment on Cushing's disease caused by aberrant adrenocorticotropin-secreting macroadenoma.
Miyoshi, T
Effect of cabergoline treatment on Cushing's disease caused by aberrant adrenocorticotropin-secreting macroadenoma. [electronic resource] - Journal of endocrinological investigation Dec 2004 - 1055-9 p. digital
Publication Type: Case Reports; Journal Article
0391-4097
10.1007/BF03345309 doi
Adenoma--complications
Adrenocorticotropic Hormone--metabolism
Cabergoline
Dopamine Agonists--pharmacology
Ergolines--pharmacology
Humans
Magnetic Resonance Imaging
Male
Middle Aged
Pituitary ACTH Hypersecretion--drug therapy
Pituitary Neoplasms--complications
Receptors, Dopamine D2--analysis
Treatment Outcome
Effect of cabergoline treatment on Cushing's disease caused by aberrant adrenocorticotropin-secreting macroadenoma. [electronic resource] - Journal of endocrinological investigation Dec 2004 - 1055-9 p. digital
Publication Type: Case Reports; Journal Article
0391-4097
10.1007/BF03345309 doi
Adenoma--complications
Adrenocorticotropic Hormone--metabolism
Cabergoline
Dopamine Agonists--pharmacology
Ergolines--pharmacology
Humans
Magnetic Resonance Imaging
Male
Middle Aged
Pituitary ACTH Hypersecretion--drug therapy
Pituitary Neoplasms--complications
Receptors, Dopamine D2--analysis
Treatment Outcome